Breaking News | GenomeWeb

Breaking News

The company said it accessioned 1,175 total samples during the quarter, up from 663 total samples in Q4 2015.

The Personalized Medicine Coalition issued a report today highlight the recent advances in precision medicine as well as the remaining challenges.

Janney analyst Paul Knight cited a rebound in the company's shares that is due to an expected easy sequential earnings comparison for Q1, among other reasons.

The worldwide distribution agreement expands Oxford's existing product and service portfolio, streamlining workflows for current customers, the company said.

The firm said that its test is the first on the market to detect RSV infection at the point of care in 13 minutes or less.

A GWAS of blood metabolite patterns in identical and non-identical twins led to common, low-frequency, and rare variants influencing metabolite levels

The company obtained out-of-state provider status from California's Medicaid program for its OVA1 test, giving it access to more than 12 million patients. 

GUSTO study researchers said maternal lifestyle, fetal genetic, and fetal epigenetic factors affect birth weight and early childhood adiposity.

The business was acquired by two private investment groups and a management group led by Prometheus Laboratories' former CEO.

The Israeli institute will share its expertise on translating research into commercially viable applications with the goal of advancing personalized medicine.

One team examined single-nucleotide variation, indels, and copy-number variations in ASD, while the other focused on large structural variations.

Mutation and expression patterns in longitudinal, multifocal, and solitary tumor samples suggest glioblastoma follows a multiverse model of evolution.

The funding will advance work focused on the discovery of a genomic configuration that correlates to chemotherapy sensitivity.

Last week, GenomeWeb's readers were most interested in Grail raising $900 million of a planned $1 billion in the first close of a Series B financing round.

The deal is expected to strengthen MedDay's existing cerebrospinal fluid-based metabolomics research platform.

The deal covers Biolog's line of cell analysis tools including its Gen III MicroPlate test panel for bacterial species identification.

Snakehead (Channa argus).

The genome may serve as a resource for those studying the fish, which is economically important in some parts of the world and an invasive species in others. 

Sanford Health and philanthropist Denny Sanford have jointly given $7 million to fund the project, which aims to sequence the genomes of 1,000 individuals.

The funding will be used to develop testing regimens to determine which CRISPR processes and techniques offer the most accurate editing rates in mouse embryos.

Angsana will support a Phase 2 basket trial for a tyrosine kinase inhibitor that targets tumors harboring TRK, ROS1, and ALK fusions.

The model incorporates clinical, serological, and gene expression factors, and could be used to tailor treatment choices.

Hygiena will sell DuPont Diagnostics products through its Qualicon Diagnostics unit.

Pages

Startup companies are taking on personalized medicine, CNET reports.

Bruce Booth writes at Life Sci VC that biotech clusters like Boston and San Francisco are getting even more consolidated.

The Verge speaks with Mark and Scott Kelly, who are the subjects of NASA's Twin Study.

In Genome Biology this week: genes linked to Hirschsprung disease, structural variant patterns in autism, and more.